Related Experiment Videos
T-cell activation in autoimmune and inflammatory diseases
1Renal Division, Laboratory of Immunogenetics and Transplantation, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Current Opinion in Nephrology and Hypertension
|June 9, 1998
Summary
Understanding autoimmunity requires examining both antigen-specific and antigen-nonspecific signals. The CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) receptors play opposing roles in T-cell activation and deactivation, influencing autoimmune disease development.
Area of Science:
- Immunology
- Autoimmunity research
- Molecular signaling pathways
Background:
- Autoimmune disease pathogenesis involves complex interactions.
- Genetic studies reveal key immune regulatory molecules.
- Antigen-specific and nonspecific signals are critical.
Purpose of the Study:
- To review the role of CD28 and CTLA-4 receptors in autoimmunity.
- To elucidate the opposing signals transduced by these receptors.
- To identify novel therapeutic targets for autoimmune diseases.
Main Methods:
- Analysis of recent experimental models.
- Review of human genetic linkage studies.
- Focus on CD28 and CTLA-4 signaling pathways.
Main Results:
- CD28 receptor signals activate T cells.
- CTLA-4 receptor signals deactivate T cells.
- Both pathways contribute to the induction of autoimmunity.
Conclusions:
- CD28 and CTLA-4 signaling are crucial in autoimmunity.
- These opposing signals offer potential therapeutic targets.
- Further research into these pathways can advance treatment strategies.